A sustainable paper-based platform for high-throughput 3D tumor models for ethical preclinical testing

3D disease models are transforming cancer research by offering more realistic depiction and improved prediction of therapy outcomes. Yet scaling and preserving these models remains a challenge. SpheroMatrix provides a simple, scalable, cryopreservable solution for reliable high-throughput testing.